Latest News for: nasalization

Edit

Padagis Extends the Shelf-Life of Naloxone HCI Nasal Spray 4 mg to 36 Months

Victoria Advocate 02 Apr 2025
The three-year shelf-life extension improves naloxone access for communities and first responders who continue to fight the growing opioid epidemic ....
Edit

Mid Yorkshire Teaching NHS Trust reduces SSI rates by 71% with Steriwave Nasal Photodisinfection

Pharmiweb 02 Apr 2025
In both orthopaedic procedures, Steriwave was deployed in addition to the current standard of care which included octenidine antiseptic nasal gel and chlorhexidine body wash.
Edit

Tiziana Life Sciences Announces Johns Hopkins University Commences Dosing Nasal Foralumab in Phase 2 Multiple Sclerosis Clinical Trial

Pharmiweb 02 Apr 2025
NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq ... Dr ... Tiziana’s innovative nasal approach has the potential to provide an improvement in efficacy as well as safety and tolerability compared to intravenous (IV) delivery ... .
Edit

Here's why school nurses need Texas law change to give new epi nasal spray to students

Austin American-Statesman 31 Mar 2025
Food and Drug Administration approved Neffy, a nasal spray form of epinephrine for people who weigh 66 pounds or more, and this month it approved a lower dose spray for children ages 4 and older who are between 33 pounds and 66 pounds.
Edit

Could oxytocin nasal spray help children with autism by making faces less overwhelming?

PsyPost 31 Mar 2025
A new study in Molecular Autism has found that a four-week course of oxytocin nasal spray in children with autism spectrum disorder was associated with decreased activity in brain regions responsible for processing faces.
Edit

Free naloxone nasal spray needed to deal with Sask. overdose spike, say front-line groups

CBC 27 Mar 2025
In the midst of an overdose crisis, organizations are calling for the Saskatchewan government to fund naloxone nasal spray, which is easier to use ... .
Edit

Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward (Form 6-K) (Polyrizon Ltd)

Public Technologies 27 Mar 2025
Studies to assess efficacy, safety, user experience, and nasal residence time as Company prepares for regulatory path forward ... · An additional clinical study assessing the nasal residence time of the PL-14 formulation.
Edit

USITC Institutes Section 337 Investigation of Certain Nasal Devices and Components Thereof (US International Trade Commission)

Public Technologies 21 Mar 2025
Claire Huber, 202-205-1819 USITC Institutes Section 337 Investigation of Certain Nasal Devices and Components Thereof ... International Trade Commission (USITC) voted to institute an investigation of certain nasal devices and components thereof.
×